Blueprint Medicines (LTS:0HOJ) Cash From Discontinued Investing Activities : $0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Blueprint Medicines Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Blueprint Medicines's cash from discontinued investing activities for the three months ended in Sep. 2024 was $0.0 Mil. It means Blueprint Medicines received $0.0 Mil from discontinued investing activities. Blueprint Medicines's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was $0.0 Mil.

Blueprint Medicines Cash From Discontinued Investing Activities Historical Data

The historical data trend for Blueprint Medicines's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueprint Medicines Cash From Discontinued Investing Activities Chart

Blueprint Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

Blueprint Medicines Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

Blueprint Medicines Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Blueprint Medicines Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Blueprint Medicines's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Blueprint Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blueprint Medicines Corp (LTS:0HOJ) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

BPMC:USA 2L9:Germany

Address

45 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.blueprintmedicines.com

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

Blueprint Medicines Headlines

No Headlines